State Medicaid Outpatient Drug Utilization and Spending, 2022

State-reported data on covered outpatient drugs paid for by Medicaid agencies under the Medicaid Drug Rebate Program. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed for the year 2022. It is provided by the U.S. Department of Health & Human Services and was last updated in April 2026.

Use Cases

• Analyzing state-level prescription volumes and costs based on reported drug name and reimbursement data.
• Tracking pharmaceutical market share within Medicaid programs based on National Drug Code (NDC) identifiers.
• Comparing drug utilization patterns across different states based on the state and prescription count fields.
• Estimating Medicaid expenditure on specific drug classes based on dollars reimbursed and drug name information.

Strengths

• Data is reported by states under a federal program, suggesting a standardized reporting mechanism.
• Includes key financial and volume metrics: dollars reimbursed and number of prescriptions.
• Covers the year 2022, providing a specific annual snapshot.
• Source is the authoritative U.S. Department of Health & Human Services.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by state Medicaid agencies under the Medicaid Drug Rebate Program.

Time Range

2022

Freshness

Last updated 2026-04 08; freshness should be verified.

Geography

United States (state-level)